chr7-138076567-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_005989.4(AKR1D1):āc.49A>Gā(p.Ser17Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000985 in 1,613,674 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005989.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AKR1D1 | NM_005989.4 | c.49A>G | p.Ser17Gly | missense_variant | 1/9 | ENST00000242375.8 | |
AKR1D1 | NM_001190907.2 | c.49A>G | p.Ser17Gly | missense_variant | 1/8 | ||
AKR1D1 | NM_001190906.2 | c.49A>G | p.Ser17Gly | missense_variant | 1/8 | ||
AKR1D1 | XM_047420763.1 | c.49A>G | p.Ser17Gly | missense_variant | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AKR1D1 | ENST00000242375.8 | c.49A>G | p.Ser17Gly | missense_variant | 1/9 | 1 | NM_005989.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251170Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135768
GnomAD4 exome AF: 0.0000547 AC: 80AN: 1461364Hom.: 1 Cov.: 30 AF XY: 0.0000399 AC XY: 29AN XY: 726954
GnomAD4 genome AF: 0.000519 AC: 79AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Aug 25, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 13, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.49A>G (p.S17G) alteration is located in exon 1 (coding exon 1) of the AKR1D1 gene. This alteration results from a A to G substitution at nucleotide position 49, causing the serine (S) at amino acid position 17 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
AKR1D1-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 21, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at